Tag Archives: medicines and healthcare products regulatory agency

Dr. Reddy’s Rituximab Biosimilar Receives Positive CHMP Opinion

Dr. Reddy's rituximab biosimilar, DRL_RI (ITUXREDI®), receives positive CHMP opinion for European launch. This affordable.....Read more